Readers include pharma professionals from:
Our loyal readership of 30,000 is made up the world's leading pharma professionals covering the following job titles/functions.
Containing expenditure in this area is a key issue; however, the cost of clinical trials continues to rise due to the increased complexity of studies. This means that making an informed decision when choosing the right partner has never been more critical.
Clinical Trials Insight provides a unique platform for information-sharing and best practice for primary decision-makers engaged in the process of managing all aspects of clinical trials. This hard-to-reach community of executives is actively occupied with purchasing the products and services needed to bring new drugs to market.
Compelling content is at the heart of Clinical Trials Insight and is provided by a combination of industry leaders and practitioners, along with key analysts and commentators.
Published in print and digital formats, this multi-platform publication is a valuable and effective way of reaching and influencing a high-spending community of industry leaders.